CNPR Product Knowledge 2 — Questions and Answers
Question 1: What is the primary purpose of a drug's package insert (PI)?
- To serve as a marketing brochure for physicians
- To provide FDA-approved prescribing information including indications, dosing, and warnings (Correct answer)
- To outline the drug's patent protection timeline
- To summarize competitor drug comparisons
Correct answer: To provide FDA-approved prescribing information including indications, dosing, and warnings
The package insert is the FDA-approved labeling that provides complete prescribing information including indications, contraindications, warnings, and dosing.
Question 2: Which pharmacokinetic parameter describes the fraction of an administered drug that reaches systemic circulation unchanged?
- Half-life
- Volume of distribution
- Bioavailability (Correct answer)
- Clearance
Correct answer: Bioavailability
Bioavailability (F) represents the proportion of a drug that reaches systemic circulation in its active form after administration.
Question 3: A medication classified as a Schedule II controlled substance by the DEA is characterized by:
- Low abuse potential with accepted medical use
- High abuse potential with accepted medical use and severe dependence risk (Correct answer)
- No accepted medical use in the United States
- Moderate abuse potential with limited physical dependence
Correct answer: High abuse potential with accepted medical use and severe dependence risk
Schedule II drugs have high abuse potential with accepted medical use, and their misuse may lead to severe psychological or physical dependence.
Question 4: What does the term 'indication' refer to in pharmaceutical product knowledge?
- The drug's mechanism of action at the receptor level
- The FDA-approved disease or condition that a drug is authorized to treat (Correct answer)
- The patient population excluded from using the drug
- The recommended storage temperature for the drug
Correct answer: The FDA-approved disease or condition that a drug is authorized to treat
An indication is the specific disease, condition, or symptom that the FDA has approved a drug to treat based on clinical evidence.
Question 5: Which of the following best describes a drug's 'therapeutic window'?
- The time period during which a drug patent is active
- The range of doses between the minimum effective dose and the minimum toxic dose (Correct answer)
- The window of time during which a drug must be taken after meals
- The age range of patients for whom the drug is approved
Correct answer: The range of doses between the minimum effective dose and the minimum toxic dose
The therapeutic window is the dosage range that provides effective treatment without causing significant adverse effects or toxicity.
Question 6: An 'off-label' use of a drug refers to:
- Using a drug after its expiration date
- Prescribing or using a drug for a purpose not approved by the FDA (Correct answer)
- Dispensing a drug without a prescription
- Substituting a brand drug with its generic equivalent
Correct answer: Prescribing or using a drug for a purpose not approved by the FDA
Off-label use means prescribing a drug for an indication, population, dose, or route not included in its FDA-approved labeling.
Question 7: What is the significance of a drug's 'black box warning' (also called a boxed warning)?
- It indicates the drug is available over-the-counter
- It is the FDA's strongest warning, highlighting serious or life-threatening risks (Correct answer)
- It signifies the drug has received accelerated FDA approval
- It means the drug is in its final stage of clinical trials
Correct answer: It is the FDA's strongest warning, highlighting serious or life-threatening risks
A boxed warning is the FDA's most serious warning, placed prominently in labeling to alert prescribers to significant risks that may cause serious injury or death.
CNPR Product Knowledge 2
What is the primary purpose of a drug's package insert (PI)?